CV

CapsoVision Inc

7.02

Jul 21 • 03:59PM ET +0.27 (4.00%)

7.30

Aftermarket • 07:51PM ET +0.28 (3.99%)

Healthcare Medical Devices USA Small NASD

Peers: ABT BSX EW MASI MDT SYK LIVN BDX TFX BAX

| Held by: VTI IWM IWO VTWO IWC VXF VTWG RSSL VTHR ITWO

Scroll to Statements

Index	RUT
Market Cap	350.74M
Enterprise Value	333.60M
Income	-26.97M
Sales	13.56M
Book/sh	0.41
Cash/sh	0.36
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	99
IPO	Jul 02, 2025

P/E	-
Forward P/E	-
PEG	-
P/S	25.87
P/B	17.30
P/C	19.56
P/FCF	-
EV/EBITDA	-
EV/Sales	24.60
Quick Ratio	3.90
Current Ratio	4.55
Debt/Eq	0.04
LT Debt/Eq	0.02
Option/Short	No / Yes

EPS (ttm)	-0.57
EPS next Y	-0.42
EPS next Q	-0.13
EPS this Y	49.51%
EPS next Y	19.23%
EPS next 5Y	-
EPS past 3/5Y	-48.82% -
Sales past 3/5Y	17.89% -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-27.76%
Sales Q/Q	0.32%
Earnings	May 14 AMC
EPS/Sales Surpr.	-15.38% -6.18%

Insider Own	41.27%
Insider Trans	0.76%
Inst Own	7.98%
Inst Trans	0.33%
ROA	-140.51%
ROE	-185.09%
ROIC	-131.05%
Gross Margin	51.67%
Oper. Margin	-199.33%
Profit Margin	-198.87%
SMA20	4.92%
SMA50	3.14%
SMA200	7.44%
Trades

Shs Outstand	49.84M
Shs Float	29.35M
Short Float	5.85%
Short Ratio	11.21
Short Interest	1.72M
52W High	15.37 -54.33%
52W Low	3.43 104.42%
Volatility	5.71% 7.59%
ATR (14)	0.48
RSI (14)	55.59
Beta	-2.28
Rel Volume	0.66
Avg Volume	153.30K
Volume	101,624

Perf Week	10.38%
Perf Month	6.20%
Perf Quarter	16.81%
Perf Half Y	12.68%
Perf YTD	-34.33%
Perf Year	57.75%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	10.00
Prev Close	6.75
Price	7.02
Change	4.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-28-25	Initiated	The Benchmark Company	Speculative Buy	$5
Jul-28-25	Initiated	Roth Capital	Buy	$6

Jul-02-26 04:05PM	CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors (GlobeNewswire) -9.20%
May-14-26 04:05PM	CapsoVision Reports First Quarter 2026 Financial Results (GlobeNewswire) -11.58%
Apr-30-26 04:05PM	CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 (GlobeNewswire) +10.62% +5.93%
Mar-27-26 08:05AM	These 16 stocks are a short seller's dream - likely losers no matter what the market does (MarketWatch)
Mar-26-26 04:05PM	CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire) -8.95%
08:00AM	Loading…
Mar-20-26 08:00AM	CapsoVision Announces $14 Million Private Placement Financing (GlobeNewswire) +11.17%
Mar-12-26 04:05PM	CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026 (GlobeNewswire)
Mar-09-26 04:05PM	CapsoVision to Participate in the 38th Annual ROTH Conference (GlobeNewswire)
Jan-02-26 12:10PM	CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus (Zacks)
Dec-29-25 04:05PM	CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus (GlobeNewswire) -10.99% +6.99%
Nov-20-25 04:05PM	CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference (GlobeNewswire)
Nov-13-25 04:05PM	CapsoVision Reports Third Quarter 2025 Financial Results (GlobeNewswire) -9.70%
Nov-12-25 07:28AM	CapsoVision Inc (CV) Q3 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
Nov-10-25 04:05PM	CapsoVision Submits Breakthrough Device Designation Application to FDA for Pancreatic Cancer Screening Capsule (GlobeNewswire) +10.22%
Nov-04-25 09:35AM	DraftKings, Flutter downgraded: Wall Street's top analyst calls (The Fly)
08:00AM	Loading…
Nov-03-25 08:00AM	CapsoVision Appoints David Garcia as Senior Vice President of Finance (GlobeNewswire)
Oct-30-25 04:05PM	CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025 (GlobeNewswire)
Oct-24-25 11:15AM	Zacks Industry Outlook Highlights Exxon Mobil, Chevron and BP (Zacks)
Sep-25-25 04:05PM	CapsoVision to Participate in the 4th Annual ROTH Healthcare Opportunities Conference (GlobeNewswire)
Aug-14-25 04:05PM	CapsoVision Reports Second Quarter 2025 Financial Results (GlobeNewswire)
10:25AM	Smart Pills Company Evaluation Report 2025 \| Medtronic, Olympus, and CapsoVision Lead with Minimally Invasive and AI-Enhanced Medical Technologies (GlobeNewswire)
Jul-31-25 04:05PM	CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025 (GlobeNewswire) -5.96%
Jul-03-25 11:50AM	CapsoVision Announces Closing of Initial Public Offering (GlobeNewswire) +25.71%
Jul-01-25 09:08PM	CapsoVision Announces Pricing of Initial Public Offering (GlobeNewswire)

CapsoVision, Inc. operates as a commercial-stage medical technology company. It engages in the development of imaging and artificial intelligence (AI) technologies that are deployed for endoscopy solutions to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. The firm developed capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn's disease. The company was founded by Kang-Huai Wang on August 1, 2005 and is headquartered in Saratoga, CA.

Co-FounderMr. Kang-Huai Wang

Compliance OfficerMr. David Garcia

Senior Vice President of Global SalesMr. Douglas Atkinson

Manager of Human ResourcesHelen Chau

Corporate ControllerAnna Krylova

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HARARI ELIYAHOU ET AL	10% Owner	Jul 17 '26	Buy	6.73	61,068	410,988	3,343,119	Jul 21 07:04 PM
HARARI ELIYAHOU ET AL	10% Owner	Jul 08 '26	Buy	6.09	81,300	495,117	3,282,051	Jul 10 08:17 PM
HARARI ELIYAHOU ET AL	10% Owner	Jun 26 '26	Buy	7.35	13,850	101,811	3,200,751	Jul 07 10:03 PM
Imperial Joanne Carol	Director	Jun 30 '26	Option Exercise	7.58	2,022	15,327	3,709	Jul 01 09:22 PM
Tsai Chen Lung	Director	Jun 30 '26	Option Exercise	7.58	2,022	15,327	4,929	Jul 01 08:19 PM
Kuo Hui Ying	Director	Jun 30 '26	Option Exercise	7.58	2,022	15,327	15,263	Jul 01 08:18 PM
King Wen-Herng Henry	Director	Jun 30 '26	Option Exercise	7.58	2,022	15,327	25,619	Jul 01 08:18 PM
Harari Michele	Director	Jun 30 '26	Option Exercise	7.58	2,022	15,327	61,065	Jul 01 08:18 PM
GOUW JULIA S	Director	Jun 30 '26	Option Exercise	7.58	2,022	15,327	4,909	Jul 01 08:17 PM
Atkinson Douglas Patrick	Head of Global Sales	May 04 '26	Option Exercise	0.34	72,571	25,000	72,571	May 06 12:50 PM
Atkinson Douglas Patrick	Head of Global Sales	May 05 '26	Option Exercise	0.57	34,786	19,692	107,357	May 06 12:50 PM
Harari Michele	Director	Dec 31 '25	Option Exercise	10.69	2,887	30,862	59,043	Dec 31 05:11 PM
GOUW JULIA S	Director	Dec 31 '25	Option Exercise	10.69	2,887	30,862	2,887	Dec 31 05:10 PM
Imperial Joanne Carol	Director	Dec 31 '25	Option Exercise	10.69	2,887	30,862	2,887	Dec 31 05:10 PM
King Wen-Herng Henry	Director	Dec 31 '25	Option Exercise	10.69	2,887	30,862	23,597	Dec 31 05:10 PM
Kuo Hui Ying	Director	Dec 31 '25	Option Exercise	10.69	2,887	30,862	13,241	Dec 31 05:09 PM
Tsai Chen Lung	Director	Dec 31 '25	Option Exercise	10.69	2,887	30,862	2,887	Dec 31 05:09 PM
Petersen Rebecca Ann	Director of Clinical Affairs	Aug 18 '25	Option Exercise	0.37	24,834	9,097	24,834	Aug 22 08:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CV

CapsoVision Inc

Upgrade your Finviz experience